Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease.
Authors
Fleisher, Adam S; Raman, Rema; Siemers, Eric R; Becerra, Lida; Clark, Christopher M; Dean, Robert A; Farlow, Martin R; Galvin, James E; Peskind, Elaine R; Quinn, Joseph F; Sherzai, Abdullah; Sowell, B Brooke; Aisen, Paul S; Thal, Leon J
Abstract
To evaluate the safety, tolerability, and amyloid beta (Abeta) response to the gamma-secretase inhibitor LY450139 in Alzheimer disease.
Publication
Archives of neurology, 2008, Vol 65, Issue 8, p1031